This company seems to have been delisted
Reason: Rebranded as Rein Therapeutics
Last recorded trade on: March 14, 2025
Source: https://aileronrx.gcs-web.com/news-releases/news-release-details/aileron-therapeutics-announces-rebranding-rein-therapeutics
Reason: Rebranded as Rein Therapeutics
Last recorded trade on: March 14, 2025
Source: https://aileronrx.gcs-web.com/news-releases/news-release-details/aileron-therapeutics-announces-rebranding-rein-therapeutics
Aileron Therapeutics
ALRN
1,80 €
Share price
9.33%
Change (1 day)
-38.70%
Change (1 year)
Categories
Aileron Therapeutics (ALRN) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : €46.17 Million
According to Aileron Therapeutics 's latest financial reports the company's total liabilities are €46.17 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aileron Therapeutics - Total liabilities on balance sheet (from 2016 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | €89.66 M | 2742.23% |
| 2022-12-31 | €3.15 M | -21.94% |
| 2021-12-31 | €4.04 M | 18.95% |
| 2020-12-31 | €3.39 M | -63.49% |
| 2019-12-31 | €9.3 M | -0.61% |
| 2018-12-31 | €9.36 M | 129.71% |
| 2017-12-31 | €4.07 M | -96.8% |
| 2016-12-31 | €0.12 B | 38.75% |
| 2015-12-31 | €91.69 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | €19.77 M | -57.18% | 🇺🇸 USA |